Series E Financing Reflects Sustained Investor Confidence in CeQur's Commercial Trajectory, Clinical Results, and Growing Demand for a Simpler Approach to Mealtime Insulin HORW, Switzerland, June 9, ...

CeQur Simplicity has received 2 recent FDA clearances that expand its clinical utility and patient applicability. These clearances will enable an expansion of the CeQur Simplicity portfolio of ...

LUCERNE, Switzerland & MARLBOROUGH, Mass.--(BUSINESS WIRE)-- CeQur®, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solutions, ...

CeQur said the series E funding will help support the next phase of commercialization for its CeQur Simplicity insulin patch. (iStock/Getty Images Plus) Swiss medtech CeQur has raised $100 million in ...

Insulin Pump Market Insulin Pump Market Dublin, March 03, 2023 (GLOBE NEWSWIRE) -- The "Insulin Pump Market - Global Outlook and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's ...

San Francisco-based SonoThera closed an oversubscribed $125 million Series B financing round, saying it will use the proceeds ...

Extended 7-Day Wear and 1-Unit Dosing Clearances, and Two ADA Posters Signal a New Standard for Mealtime Insulin Management HORW, Switzerland, June 4, 2026 /PRNewswire/ -- CeQur®, the company ...

Novel, discreet, and simple insulin-delivery system can replace need for mealtime injections for people with diabetes Largest fundraising to date for a privately held medtech company in Europe was led ...